Caribou Biosciences Inc. (CRBU)
undefined
undefined%
At close: undefined
1.91
0.75%
After-hours Dec 13, 2024, 04:57 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 34.48M 13.85M 9.60M 12.36M 5.79M
Cost of Revenue 112.08M 3.64M 984.00K 34.42M 23.64M
Gross Profit -77.60M 10.21M 8.61M -22.06M -17.85M
Operating Income -116.06M -106.40M -66.98M -36.12M -34.30M
Interest Income 10.70M 4.60M 148.00K 236.00K 1.05M
Pretax Income -101.88M -99.35M -66.60M -36.13M -30.97M
Net Income -102.07M -99.42M -66.92M -34.31M -23.43M
Selling & General & Admin 38.46M 38.02M 24.32M 14.06M 16.46M
Research & Development 112.08M 82.23M 52.26M 34.42M 23.64M
Other Expenses - 7.18M -1.35M 514.00K -
Operating Expenses 150.54M 120.25M 76.58M 48.48M 40.09M
Interest Expense - - 8.00K 20.00K 4.00K
Selling & Marketing Expenses - - - - -
Cost & Expenses 150.54M 120.25M 76.58M 48.48M 40.09M
Income Tax 193.00K 70.00K 321.00K -1.82M -7.54M
Shares Outstanding (Basic) 73.81M 60.80M 60.26M 59.97M 59.97M
Shares Outstanding (Diluted) 73.81M 60.80M 60.26M 59.97M 59.97M
EPS (Basic) -1.38 -1.64 -1.11 -0.57 -0.39
EPS (Diluted) -1.38 -1.64 -1.11 -0.57 -0.39
EBITDA -112.53M -104.78M -66.00M -35.21M -30.21M
Depreciation & Amortization 3.52M 3.64M 984.00K 900.00K 751.00K